ARTICLE | Clinical News
Gestiva regulatory update
February 5, 2007 8:00 AM UTC
FDA granted Orphan Drug designation for Gestiva to prevent preterm birth in women with a history of preterm delivery. ADZA received an approvable letter from FDA for Gestiva requesting an additional a...